We are live on
!
Find out more
NB
Norinchukin Bank Portfolio holdings
AUM
$10.3B
1-Year Est. Return
30.79%
This Fund
S&P 500
This Quarter
Est. Return
+0.43%
1 Year Est. Return
+30.79%
3 Year Est. Return
+93.27%
5 Year Est. Return
+114.46%
10 Year Est. Return
+399.71%
AUM
$7.2B
AUM Growth
+$279M
(+4%)
Cap. Flow
+$290M
Cap. Flow
% of AUM
4.03%
Top 10 Holdings %
Top 10 Hldgs %
48.57%
Holding
550
New
11
Increased
499
Reduced
31
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$41M |
| 2 |
TJX Companies
TJX
|
+$32.6M |
| 3 |
Fastenal
FAST
|
+$30.3M |
| 4 |
ResMed
RMD
|
+$26.1M |
| 5 |
S&P Global
SPGI
|
+$24.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$29.8M |
| 2 |
Emerson Electric
EMR
|
+$14.4M |
| 3 |
Colgate-Palmolive
CL
|
+$12M |
| 4 |
3M
MMM
|
+$10.2M |
| 5 |
Illinois Tool Works
ITW
|
+$8.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.75% |
| 2 | Technology | 15.31% |
| 3 | Healthcare | 8.37% |
| 4 | Consumer Discretionary | 7.45% |
| 5 | Industrials | 6.79% |
Similar funds
MOACM
DCP
GIM
LWCFA
BSL
PCIA
HI
ECU
Norinchukin Bank's Q3 2021 Portfolio in Review
As of Q3 2021, Norinchukin Bank held 550 positions worth $7.2B, up 4% from $6.92B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Norinchukin Bank deployed $290M of net new capital in Q3 2021, opening 11 new positions and adding to 499 existing holdings. Its largest new stake was Bio-Techne: 13,048 shares worth $1.58M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 40% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Becton Dickinson, an estimated $29.8M trimmed.
- Norinchukin Bank's largest Q3 2021 buy was Bio-Techne: 13,048 shares worth $1.58M.
- Norinchukin Bank added most to Invesco QQQ Trust in Q3 2021, an estimated $41M increase.
- Norinchukin Bank's biggest Q3 2021 reduction was Becton Dickinson, cutting an estimated $29.8M.
- Norinchukin Bank fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.83M.
- Norinchukin Bank's ten largest holdings make up 49% of its $7.2B portfolio in Q3 2021.
- Norinchukin Bank opened 11 new positions and closed 4 in Q3 2021.
- Norinchukin Bank's portfolio value rose 4% quarter-over-quarter to $7.2B.
Based on Norinchukin Bank's 13F filing for Q3 2021, filed 9 Nov 2021.